On January 7, 2020, the Director of the US Office of Management and Budget (OMB) issued a Draft Memorandum (the Memorandum) to all federal “implementing agencies” regarding the development of regulatory and non-regulatory...more
1/20/2020
/ 21st Century Cures Act ,
Artificial Intelligence ,
Big Data ,
Data Privacy ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Machine Learning ,
Medical Devices ,
OMB ,
Policy Memorandums ,
Regulatory Agenda ,
Technology ,
Telehealth
On January 7, 2020, the Director of the US Office of Management and Budget (OMB) issued a Draft Memorandum (the Memorandum) to all federal “implementing agencies” regarding the development of regulatory and non-regulatory...more
1/16/2020
/ 21st Century Cures Act ,
Artificial Intelligence ,
Big Data ,
Data Privacy ,
Federal Grants ,
Food and Drug Administration (FDA) ,
Medical Devices ,
OMB ,
Policy Memorandums ,
Public Agencies ,
Public Interest ,
Regulatory Agencies ,
Regulatory Agenda ,
Risk Assessment ,
Risk Management ,
Technology ,
Telehealth ,
White Papers
Introduction -
Throughout 2017, the health care and life science industries experienced a widespread proliferation of digital health innovation that presents challenges to traditional notions of health care delivery and...more
1/10/2018
/ 21st Century Cures Act ,
Artificial Intelligence ,
Biometric Information ,
Consumer Protection Act ,
Cyber Threats ,
Cybersecurity ,
Data Breach ,
Department of Health and Human Services (HHS) ,
Digital Health ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Health Information Technologies ,
Health Insurance ,
Life Sciences ,
OIG ,
Privacy Policy ,
Research and Development ,
TCPA ,
Telehealth